Personal details: Dr. Uwe Salzer is the new Chief Financial Officer at RIEMSER Pharma GmbH

Riems/Berlin, September 1, 2016. As from today, Dr. Uwe Salzer is the new Chief Financial Officer at RIEMSER Pharma GmbH. Between 2011 and 2015, Dr. Salzer held the position of Chief Financial Officer at CABB GmbH in Sulzbach am Taunus and also fulfilled the same role at HC Starck in Goslar between 2008 and 2010. Prior to 2008, he held senior positions at Degussa (now Evonik), including CFO at Degussa Corporation in the USA. He is a recognized expert in his field and possesses extensive entrepreneurial knowledge and experience. Dr. Salzer has already acted in a consulting role to RIEMSER Pharma GmbH before. In tandem with CEO Konstantin von Alvensleben, he will continue to pursue and implement the sustainable growth strategy at RIEMSER.

About RIEMSER Pharma GmbH: RIEMSER Pharma is a company that is expert in the licensing, marketing and sale of specialist therapeutics with a high medical requirement. It offers its own product portfolio covering different therapeutic fields ranging from oncology and neuroscience to infectious diseases and dermatology. RIEMSER Pharma GmbH has its headquarters in Germany (Riems, Berlin, Greifswald, Schiffweiler) and has other subsidiaries located in France and the UK. The company employs more than 230 staff throughout Europe. 

 

Press contact:

Tim-Åke Pentz
HOSCHKE
CONSORTEN
Public Relations GmbH
Heimhuder Straße 56, 20148 Hamburg
Phone: +49 40 3690 5086
Email: t.pentz@hoschke.de